The energy transduction mechanism of Na,K-ATPase studied with iron-catalyzed oxidative cleavage.
This paper extends our recent report on specific iron-catalyzed oxidative cleavages of renal Na,K-ATPase and effects of E1 left arrow over right arrow E2 conformational transitions (Goldshleger, R. , and Karlish, S. J. D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 9596-9601). The experiments indicate that only peptide bonds close to a bound Fe2+ ion are cleaved, and provide evidence on proximity of the different cleavage positions in the native enzyme. A sequence HFIH near trans-membrane segment M3 appears to be involved in Fe2+ binding. Previously we hypothesized that E2 and E1 conformations are characterized by formation or relaxation of interactions within the alpha subunit at or near highly conserved sequences, TGES in the minor cytoplasmic loop and CSDK, MVTGD, and VNDSPALKK in the major cytoplasmic loop. This concept has been tested by examining iron-catalyzed cleavage in both non-phosphorylated and phosphorylated conformations and effects of phosphate, vanadate, and ouabain. The results imply that both E1 left arrow over right arrow E2 and E1P left arrow over right arrow E2P transitions are indeed associated with formation and relaxation of interactions between cytoplasmic domains, comprising the minor loop plus N-terminal tail leading into M1 and major loop, respectively. Furthermore, it appears that either non-covalently or covalently bound phosphate bind near CSDK and MVTGD, and Mg2+ ions may bind to residues within TGES and VNDSPALKK and to bound phosphate. Thus cytoplasmic domain interactions seem to occur within or near the active site. We discuss the relationship between structural changes in the cytoplasmic domain and movements of trans-membrane segments that lead to cation transport. Presumably conformation-dependent formation and relaxation of domain interactions underlie energy transduction in all P-type pumps.
Goldshleger
R
R
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.
Karlish
S J
SJ
D000818:Animals; D002384:Catalysis; D002918:Chymotrypsin / Q000378:metabolism; D007501:Iron / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology; D008861:Microsomes / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology; D010710:Phosphates / Q000494:pharmacology; D010766:Phosphorylation; D011487:Protein Conformation; D051381:Rats; D012413:Rubidium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013552:Swine; D014638:Vanadates / Q000494:pharmacology
D010710:Phosphates; D014638:Vanadates; D010042:Ouabain; D012964:Sodium; D007501:Iron; D002918:Chymotrypsin; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium